- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 14-01-2026: General Updates
14-01-2026 | 11:10 pm
14-01-2026 | 11:10 pm
Cipla's top-3 US product, Lanreotide, faces limited supply as its exclusive manufacturer temporarily paused production due to manufacturing issues. Re-supply is expected later, potentially impacting US revenue.
No comments yet. Be the first to comment!